Brain tumours Flashcards

1
Q

what brain tumours are associated with NF2?

A

acoustic schwannomas, ependymomas, meningiomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what brain tumours are associated with NF1?

A

LGG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what brain tumours are associated with p53 mutations?

A

HGG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the characteristic mutation in DIPG

A

H3 K27M

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what three chemotherapy regimens are used in LGG?

A

carboplatin/vincristine, vinblastine alone,

thioguanine, procarbazine, CCNU, and vincristine (TPCV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

abnormalities of what pathway are found in LGG?

A

MAPK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the most common abnormality found in LGG?

A

BRAF KIAA1549 fusion (found in 60%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the high-grade gliomas?

A

GBM (IDH wt, IDH mutant)
Anaplastic astrocytoma
DIPG (H3K27M mutant)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the low grade gliomas?

A

diffuse astrocytoma
pilocytic astrocytoma
PXA
SEGA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Top 3 brain tumours in childhood

A
  • gliomas
  • medulloblastoma
  • ependymoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What condition predisposes to LGG? (name gene)

A

20% of patients with NF1 develop LGG (commonly OPG)

Gene: NF1 (17q11.2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does dabrafenib do?

A

BRAF inhibitor works in V600E mutated tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what does trametinib do?

A

MEK inhibitor works in KIAA1549 BRAF fusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what tumour are patients with tuberous sclerosis predisposed to develop?

A

subependymal giant cell astrocytoma (SEGA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what targeted treatment can you consider for SEGAs

A

sirolimus, everolimus (mTOR inhibitor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what types of tumours do patients with LFS develop

A

Adrenocorticocarcinoma, HGG, sarcomas, choroid plexus carcinomas, medulloblastoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what gene causes Gorlin syndrome?

A

PTCH1
aka nevoid basal cell carcinoma syndrome
increased risk of medulloblastoma (SHH-activated)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what conditions are due to mutations in APC

A

Familial adenomatous polyposis (gardner, turcot)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is lynch syndrome

A

hereditary non-polyposis colorectal cancer (HNPCC), endometrial cancer, ovarian, stomach etc. Due to MMR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what germline mutations predispose to rhabdoid tumours

A

SMARCB1 (loss of INI1)

SMARCA4 (loss of BRG1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

six side effects of brain RT (early / late)

A
  • fatigue
  • rash
  • cognitive impairment
  • edema
  • parotitis
  • late: meningiomas, SMNs, endocrinopathies, cerebrovascular events, blindness , ototoxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

most common locations of LGG

A

cerebellar, hemispheric, OPG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

how do you stage a LGG

A

MRI brain (only do spine if there are concerning symptoms)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

A LGG in cerebellum - what genetic aberration are you likely to find?

A

BRAF KIAA1549 fusion

74%) - less likely to be BRAF V600E (only 4% are in cerebellum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
prognostic factors for LGG
- GTR - location (optic nerve > optic pathway/chiasm) - mets - intracranial htn at presentation - nf1 (better outcomes) - BRAF KIAA1549 fusion (better) - BRAF V600E mutation (more invasive)
26
chemo for LGG
carbo + vincristine TPCV (thioguanine, procarbazine, CCNU, vincristine) vinblastine monotherapy
27
three brain tumours that do not need biopsy
DIPG NGGCT (secreting) OPG (NF1)
28
tumours in what area can cause parinaud syndrome
tectum, pineal gland (midbrain) - caused by compression of the medial longitudinal fasiculus
29
what conditions increase the risk of HGG?
p53 APC mutations (FAP) exposure to RT
30
prognostic factors for HGG
``` H3K27M (poor) IDH-1 mutant (favourable) Histology (AA better than GBM) H3 G34 mutations - intermediate prognosis, older cildren BRAF V600E (PXA-like) - favourable MYC-N amp - poor ```
31
Chemo for HGG
Lomustine (CCNU), vincristine, prednisone
32
how does DIPG present
short duration of symptoms, classic triad: - long tract signs - cranial nerve palsy - ataxia
33
Treatment of craniopharyngioma
- Maximal surgery - If GTR obtained; observe only - If
34
What neuroendocrinopathies are seen with craniopharyngioma?
``` growth hormone deficiency (in 100%) amenorrhea DI adrenal insufficiency hypothyroidism ```
35
when do ATRTs present
Present in infancy, young children 75% in age < 3 yr of age Most common malignant tumour in age <6m
36
how do you stage ATRT
MRI brain/spine, CSF, renal US (to look for synchronous renal rhabdoid if high suspicion for germline mutation)
37
what targeted therapy can be used to tumours with SMARCB1 mutations?
EZH2 inhibitors (tazemetostat)
38
treatment of ATRT
GTR RT High dose chemotherapy with alkylators followed by stem cell rescue
39
where do choroid plexus tumours present
usually lateral ventricles
40
which GCTs secrete AFP?
yolk sac tumours
41
which GCTs secrete b-HCG?
choriocarcinoma
42
types of NGGCT
``` choriocarcinoma yolk sac tumour teratoma embryonal carcinoma mixed ```
43
where does ependymoma most commonly present
posterior fossa - 55% infratentorial
44
genetic aberrations in supratentorial ependymoma
RELA positive (70% of supratentorial ependymomas), YAP1 fusion positive (young children, very good prognosis)
45
what are prognostic features in ependymoma
- gain of chr 1q (poor) - YAP fusion (good) - anaplastic - extent of resection
46
RT in ependymoma
54 Gy - can be focal (no need for CSI unless multifocal tumour / disseminated disease)
47
what are the four histologic patterns in medulloblastoma
- classic - medulloblastoma with extensive nodularity (MBEN) - desmoplastic - anaplastic
48
standard risk medullo
> 3 yrs GTR < 1.5 cm3 residual no metastasis not anaplastic
49
high risk medullo
> 1.5cm3 residual disease mets by spine MRI or lumbar CSF diffusely anaplastic histology
50
medullo subgroups
Wnt-activated Shh-activated Group 3 Group 4
51
what type of medullo affects infants
``` Group 3 (most common) Shh-activated ```
52
Genetic aberrations in Wnt-activated medullo
beta-catenin (CTNNB1) monosomy 6 (85%) SMARCA4 (25%) associated with germline APC mutations (rare, < 5%)
53
Genetic aberrations in Shh-activated medullo
PTCH1, SUFU | Can have Myc-n amplification
54
Genetic aberrations in group 3 medullo
can have myc-n amplification (15%) SMARCA4 mutations (10%) i17q Often infants, metastatic at presentation
55
Genetic aberrations in group 4 medullo
can have myc-n amplification i17q enriched can have whole chr 11 loss (good prognosis)
56
what age group does better in Wnt-activated medullo?
< 16 yrs
57
which medullo subgroup is associated with p53 mutations
Shh-activated
58
treatment for SR medullo
GTR if possible CSI with lower dose (23.4 Gy) with boost to posterior fossa + weekly VCR followed by maintenance cisplatin-based chemotherapy
59
treatment for HR medullo
GTR if possible CSI with regular dose (36 Gy with boost to post fossa to 54 Gy) + weekly VCR followed by maintenance chemo (cisplat, VCR, cyclo)
60
other tumours with BRAF V600E mutation or KIAA1549 fusion
- melanomas (Spitzoid) - papillary thyroid cancers - acinar pancreatic carcinomas - non-small‐cell lung cancers - colorectal cancers - papillary craniopharyngioma
61
what genetic aberration is seen in craniopharyngioma in children
activating mutations of beta-catenin
62
non-surgical options in craniopharyngioma management
- Radiotherapy - Intracystic therapy - ie, Interferon-α 2a, bleomycin - Cyst drainage (can be done via ommaya) - Systemic interferon (generally for recurrent cranio)